Abbott Laboratories

NYSE: ABT · Real-Time Price · USD
131.19
1.91 (1.48%)
At close: Aug 15, 2025, 10:14 AM

Abbott Laboratories Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
7.62B 6.9B 9.88B 9.8B
Short-Term Investments
351M 383M 288M 450M
Long-Term Investments
886M 799M 766M 903M
Other Long-Term Assets
15.38B 5.97B 4.92B 3.97B
Receivables
6.92B 6.57B 6.22B 6.49B
Inventory
6.19B 6.57B 6.17B 5.16B
Other Current Assets
2.57B 2.26B 2.66B 2.35B
Total Current Assets
23.66B 22.67B 25.22B 24.24B
Property-Plant & Equipment
11.73B 11.28B 10.28B 10.11B
Goodwill & Intangibles
29.75B 32.49B 33.25B 35.97B
Total Long-Term Assets
57.76B 50.54B 49.21B 50.96B
Total Assets
81.41B 73.21B 74.44B 75.2B
Account Payables
4.2B 4.29B 4.61B 4.41B
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
1.75B 1.32B 2.48B 999M
Other Current Liabilities
5.91B 6.13B 6.5B 5.77B
Total Current Liabilities
14.16B 13.84B 15.49B 13.11B
Long-Term Debt
12.63B 13.6B 14.52B 17.3B
Other Long-Term Liabilities
4.46B 4.78B 4.74B 5.74B
Total Long-Term Liabilities
19.36B 20.55B 22.04B 26.07B
Total Liabilities
33.51B 34.39B 37.53B 39.17B
Total Debt
15.28B 15.87B 17.95B 19.25B
Common Stock
25.15B 24.87B 24.71B 24.47B
Retained Earnings
47.26B 37.55B 35.26B 31.53B
Comprehensive Income
-7.91B -7.84B -8.05B -8.37B
Shareholders Equity
47.66B 38.6B 36.69B 35.8B
Total Investments
1.24B 1.18B 1.05B 1.35B